GlobeNewswire - Licensing AgreementsContains the last 20 releasesuuid:9d8953de-d0fa-4db9-bc7f-80a746068777;id=99962021-02-04T16:35:43Znewsdesk@globenewswire.com (NewsDesk)http://www.10gbhost.com/LegacyRss?Length=4newsdesk@globenewswire.comhttp://www.10gbhost.com/news-release/2021/02/04/2170185/0/en/Alphageneron-Pharmaceuticals-Signed-Exclusive-License-Agreement-With-Multimmune-GmbH-For-Natural-Killer-Cell-Platform-Therapy-Worldwide.htmlAlphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide2021-02-04T16:35:43Z2021-02-06T06:08:09ZCAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its clinical stage autologous Natural Killer (“NK”) cell therapy and companion diagnostic platform, for all fields worldwide.]]>2170185enGlobeNewswire Inc.Alphageneron PharmaceuticalsThu, 04 Feb 2021 16:36 GMTLicensing AgreementsBiotechPharmaOncologyResearchcolorectal cancerlung cancerhttp://www.10gbhost.com/news-release/2021/02/04/2170086/0/en/Amarillo-receives-License-to-Install-for-Posse.htmlAmarillo receives License to Install for Posse2021-02-04T14:40:45Z2021-02-06T06:08:09ZTORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- State regulators have approved the Posse Gold Mine, said Amarillo Gold Corporation today after receiving the License to Install (LI) for its project on the Mara Rosa Property in Goiás, Brazil. The license permits the company to start construction. ]]>2170086enGlobeNewswire Inc.Amarillo Gold Corp.Thu, 04 Feb 2021 14:41 GMTLicensing AgreementsAmarillo Gold CorporationAmarilloAmarillo GoldgoldAGCsocial licenseLIlicense to installbrazilundervalued gold companyTSXhttp://www.10gbhost.com/news-release/2021/02/03/2169085/0/zh-hant/%E5%A4%A9%E6%BC%94%E8%97%A5%E6%A5%AD%E5%AE%A3%E4%BD%88%E8%88%87-Exelixis-%E7%B0%BD%E8%A8%82%E5%90%88%E4%BD%9C%E8%A8%B1%E5%8F%AF%E5%8D%94%E8%AD%B0-%E5%85%B1%E5%90%8C%E9%96%8B%E7%99%BC%E5%85%B7%E6%9C%89%E6%9B%B4%E4%BD%B3%E5%AE%89%E5%85%A8%E6%80%A7%E5%92%8C%E6%9C%89%E6%95%88%E6%80%A7%E7%9A%84%E5%8E%9F%E5%89%B5%E6%96%B0%E5%9E%8B%E5%AE%89%E5%85%A8%E6%8A%97%E9%AB%94%E5%81%B6%E8%81%AF%E8%97%A5%E7%89%A9.html天演藥業宣佈與 Exelixis 簽訂合作許可協議,共同開發具有更佳安全性和有效性的原創新型安全抗體偶聯藥物2021-02-03T13:24:22Z2021-02-06T06:08:09ZExelixis 將使用天演藥業自主研發及擁有精準掩蔽功能的安全抗體技術 (SAFEbody),共同開發創新的安全抗體偶聯藥物 (ADC),此安全抗體技術可以提高抗體偶聯藥物 (ADC) 的治療指數]]>2169085zh-HantGlobeNewswire Inc.Adagene, Inc.Wed, 03 Feb 2021 13:25 GMTLicensing Agreementshttp://www.10gbhost.com/news-release/2021/02/03/2168759/0/en/Artificial-Lung-Devices-Pipeline-Looks-Promising-a-Positive-Push-to-the-Market-Size-Growth-in-the-Future-estimates-DelveInsight.htmlArtificial Lung Devices Pipeline Looks Promising, a Positive Push to the Market Size Growth in the Future, estimates DelveInsight 2021-02-03T08:00:00Z2021-02-06T06:08:09ZWith 20+ key companies and 23+ pipeline devices in the horizon Artificial Lung Devices Pipeline Landscape presents quite an appealing picture for the coming decade. ]]>2168759enGlobeNewswire Inc.DelveInsight Business Research LLPWed, 03 Feb 2021 08:00 GMTHealthCompany AnnouncementPress releasesMarket Research ReportsLicensing AgreementsArtificial lung devices marketHealthcare devices marketArtificial lung devicesArtificial lungMedtronicCOVID-19Abiomedhttp://www.10gbhost.com/news-release/2021/02/02/2168558/0/en/Medexus-Pharmaceuticals-and-medac-GmbH-enter-into-a-License-Agreement-for-First-in-Class-Conditioning-Agent-for-Hematopoietic-Stem-Cell-Transplantation-Treosulfan-in-the-United-Sta.htmlMedexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States2021-02-02T19:21:32Z2021-02-06T06:08:09ZOrphan Designated Drug with August 2021 PDUFA date]]>2168558enGlobeNewswire Inc.Medexus Pharmaceuticals IncTue, 02 Feb 2021 19:21 GMTHealthLicensing AgreementsProduct / Services Announcementhttp://www.10gbhost.com/news-release/2021/02/02/2168331/0/en/Ocugen-and-Bharat-Biotech-Announce-Execution-of-Definitive-Agreement-for-the-Commercialization-of-COVAXIN-in-the-US-Market.htmlOcugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN? in the US Market2021-02-02T14:27:06Z2021-02-06T06:08:09ZMALVERN, Pa. and HYDERABAD, India, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, and Bharat Biotech, a global leader in vaccine innovation, today announced they have entered into a definitive agreement to co-develop, supply, and commercialize Bharat Biotech’s COVAXIN?, an advanced stage whole-virion inactivated COVID-19 vaccine candidate, for the United States market.]]>2168331enGlobeNewswire Inc.OcugenTue, 02 Feb 2021 14:27 GMTHealthLicensing Agreementscovid-19vaccineocugenhttp://www.10gbhost.com/news-release/2021/02/01/2167287/0/zh-hans/%E5%A4%A9%E6%BC%94%E8%8D%AF%E4%B8%9A%E5%AE%A3%E5%B8%83%E4%B8%8EExelixis%E7%AD%BE%E8%AE%A2%E5%90%88%E4%BD%9C%E8%AE%B8%E5%8F%AF%E5%8D%8F%E8%AE%AE-%E5%85%B1%E5%90%8C%E5%BC%80%E5%8F%91%E5%85%B7%E6%9C%89%E6%9B%B4%E4%BD%B3%E5%AE%89%E5%85%A8%E6%80%A7%E5%92%8C%E6%9C%89%E6%95%88%E6%80%A7%E7%9A%84%E5%8E%9F%E5%88%9B%E6%96%B0%E5%9E%8B%E5%AE%89%E5%85%A8%E6%8A%97%E4%BD%93%E5%81%B6%E8%81%94%E8%8D%AF%E7%89%A9.html天演藥業宣布與Exelixis簽訂合作許可協議,共同開發具有更佳安全性和有效性的原創新型安全抗體偶聯藥物2021-02-01T13:05:00Z2021-02-06T06:08:09ZExelixis將使用天演藥業自主研發的擁有精準掩蔽功能的安全抗體技術(SAFEbody)共同開發創新的安全抗體偶聯藥物(ADC),安全抗體技術可以提高抗體偶聯藥物(ADCs)治療指數(Therapeutic Index)]]>2167287zh-HansGlobeNewswire Inc.Adagene, Inc.Mon, 01 Feb 2021 13:05 GMTLicensing Agreementshttp://www.10gbhost.com/news-release/2021/02/01/2167224/0/en/PharmaTher-Signs-Exclusive-Worldwide-License-Agreement-for-Patented-Microneedle-Delivery-Technology-to-Deliver-Ketamine.htmlPharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine2021-02-01T12:59:00Z2021-02-06T06:08:09ZTORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that PharmaTher has entered into an Exclusive Worldwide Patent and Know-how License Agreement (the “Agreement”) with The Queen’s University of Belfast (“QUB”) for the development and commercialization of a patented hydrogel-forming microneedle delivery technology developed by Professor Ryan Donnelly to support PharmaTher’s product and clinical development initiatives with ketamine. ]]>2167224enGlobeNewswire Inc.Newscope Capital CorporationMon, 01 Feb 2021 12:59 GMTLicensing AgreementsHealthagreementhttp://www.10gbhost.com/news-release/2021/01/28/2166305/0/en/Murphy-USA-and-Core-Mark-Renew-Strategic-Supply-Agreement.htmlMurphy USA and Core-Mark Renew Strategic Supply Agreement2021-01-28T21:30:00Z2021-02-06T06:08:09ZEL DORADO, Ark. and WESTLAKE, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Murphy USA Inc. (NYSE: MUSA) and Core-Mark Holding Company, Inc. (NASDAQ: CORE) announced today that they have entered into a new five year supply agreement whereby Core-Mark will continue to serve as the primary wholesale distributor to Murphy USA, delivering over 75% of the merchandise sold in their stores. ]]>2166305enGlobeNewswire Inc.Murphy USA Inc.Thu, 28 Jan 2021 21:30 GMTLicensing AgreementsPartnershipsProduct / Services Announcementhttp://www.10gbhost.com/news-release/2021/01/28/2165917/0/en/Black-Rock-Petroleum-Company-announces-site-inspection-and-due-diligence-review.htmlBlack Rock Petroleum Company announces site inspection and due diligence review2021-01-28T14:00:00Z2021-02-06T06:08:09ZLos Angeles Ca, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Los Angeles, CA – January 28, 2021
Black Rock Petroleum announces site inspection and due diligence review of two hydrocarbon exploration licenses? in Far East? Region of Sakhalin Island, Russian Federation. ?
Black Rock Petroleum Company (OTC:BKRP), a Nevada corporation. announced today that it has approved a site inspection and due diligence review of two vast onshore oil and gas fields on Sakhalin Island in the Russian Federation.]]>2165917enGlobeNewswire Inc.Black Rock PetroleumThu, 28 Jan 2021 14:00 GMTCompany AnnouncementLicensing AgreementsJoint VenturePartnershipshttp://www.10gbhost.com/news-release/2021/01/28/2165817/0/en/Eco-Innovation-Enters-Cannabis-Sector-by-Acquiring-Exclusive-Rights-to-Disruptive-Supercritical-Extraction-Technology-for-Bioactive-Compounds.htmlEco Innovation Enters Cannabis Sector by Acquiring Exclusive Rights to Disruptive Supercritical Extraction Technology for Bioactive Compounds2021-01-28T13:00:00Z2021-02-06T06:08:09ZVAN NUYS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Eco Innovation Group, Inc. ("ECOX" or the "Company") (OTC:ECOX), an innovative company aggregating investments in new technologies that promote environmental and social well-being, and the advancement of green energy solutions, is excited to announce the signing of an exclusive license agreement (the “Agreement”) with Glytech, LLC (“Glytech”), a California-based producer of disruptive supercritical extraction technology for bioactive compounds. ]]>2165817enGlobeNewswire Inc.Eco Innovation Group, Inc.Thu, 28 Jan 2021 13:02 GMTLicensing Agreementscannibisnew technologygreen techrenewable energyhttp://www.10gbhost.com/news-release/2021/01/27/2165071/0/en/Motorsport-Games-and-the-ACO-Enhance-and-Extend-Le-Mans-Esports-Series-Joint-Venture.htmlMotorsport Games and the ACO Enhance and Extend Le Mans Esports Series Joint Venture2021-01-27T13:30:00Z2021-02-06T06:08:09ZTen Year Exclusive License for Video Games Now Part of this Joint Venture ]]>2165071enGlobeNewswire Inc.Motorsport Gaming US LLCWed, 27 Jan 2021 13:30 GMTJoint VentureLicensing Agreementshttp://www.10gbhost.com/news-release/2021/01/26/2164467/0/en/The-International-Chili-Society-Now-Accepting-Applications-for-2021-Sanctioning.htmlThe International Chili Society Now Accepting Applications for 2021 Sanctioning2021-01-26T15:00:00Z2021-02-06T06:08:09ZDALLAS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- After almost a year of postponing chili events and delaying certification of new ones, the International Chili Society (ICS) announced today that it is once again accepting applications for chili events seeking professional sanctioning for the 2021 season and beyond.]]>2164467enGlobeNewswire Inc.International Chili SocietyTue, 26 Jan 2021 15:00 GMTArts & EntertainmentFeature ArticleFoodLicensing AgreementsPress releaseschili eventchili cook offchili tastingworld chilinew eventschili festfood festsanctioningchili sanctioninghttp://www.10gbhost.com/news-release/2021/01/25/2163525/0/en/Relief-Therapeutics-and-Acer-Therapeutics-Sign-Option-Agreement-for-Exclusivity-to-Negotiate-a-Collaboration-and-License-Agreement-for-the-Worldwide-Development-and-Commercializati.htmlRelief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the?Worldwide Development and Commercialization of ACER-001 for the Treatment of?Urea Cycle Disorders and Maple Syrup Urine Disease2021-01-25T13:35:47Z2021-02-06T06:08:09ZAcer to receive $1 million payment to obtain exclusivity and a $4 million loan from Relief ]]>2163525enGlobeNewswire Inc.Acer Therapeutics Inc.Mon, 25 Jan 2021 13:36 GMTLicensing Agreementshttp://www.10gbhost.com/news-release/2021/01/25/2163450/0/en/BrainsWay-Signs-Exclusive-Distribution-Agreement-with-Gaelan-Medical-Trade-LLC.htmlBrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC2021-01-25T13:00:00Z2021-02-06T06:08:09ZFollowing Historic Abraham Accords, Israel’s Deep Transcranial Magnetic Stimulation (Deep TMS) Treatment to Come to the United Arab Emirates]]>2163450enGlobeNewswire Inc.Brainsway Ltd.Mon, 25 Jan 2021 13:01 GMTLicensing AgreementsProduct / Services Announcementhttp://www.10gbhost.com/news-release/2021/01/22/2163065/0/en/HCI-Group-Agrees-to-Acquire-Insurance-Business-in-Four-Northeast-States-from-United-Insurance-Holdings-Corp.htmlHCI Group Agrees to Acquire Insurance Business in Four Northeast States from United Insurance Holdings Corp.2021-01-22T21:30:00Z2021-02-06T06:08:09ZTAMPA, Fla., Jan. 22, 2021 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE: HCI), an InsurTech company with operations in insurance, software development and real estate, has entered into a renewal rights agreement, dated January 18, 2021, with United Insurance Holding Corp. (NASDAQ: UIHC) pursuant to which United is to transition to HCI all its personal lines insurance business in the states of Connecticut, New Jersey, Massachusetts and Rhode Island. ]]>2163065enGlobeNewswire Inc.HCI Group, Inc.Fri, 22 Jan 2021 21:30 GMTCompany AnnouncementLicensing Agreementshttp://www.10gbhost.com/news-release/2021/01/21/2161920/0/en/ViaDerma-Inc-Completes-a-Licensing-Agreement-with-a-Group-of-Affiliate-Wound-Care-Medical-Practices-Operating-in-Six-States.htmlViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States2021-01-21T10:00:00Z2021-02-06T06:08:09ZLOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practices. The medical practices provide advanced wound care treatment to homebound patients and are currently operating in six states. ViaDerma’s goal is to increase its presence to medical practices in sixteen states this year and to be in all fifty states by the end of 2022.]]>2161920enGlobeNewswire Inc.ViaDerma LicensingThu, 21 Jan 2021 10:00 GMTLicensing Agreementshttp://www.10gbhost.com/news-release/2021/01/20/2161622/0/en/Canada-Coal-Announces-Ayurcann-Receipt-of-Amendment-to-Standard-Processing-Licence-to-Allow-for-Sales.htmlCanada Coal Announces Ayurcann Receipt of Amendment to Standard Processing Licence to Allow for Sales2021-01-20T16:05:05Z2021-02-06T06:08:09ZTHIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.]]>2161622enGlobeNewswire Inc.Canada Coal Inc.Wed, 20 Jan 2021 16:05 GMTHealthLicensing AgreementsProduct / Services Announcementhttp://www.10gbhost.com/news-release/2021/01/20/2161371/0/en/Gritstone-and-Genevant-Sciences-Announce-License-Agreement-for-COVID-19-Vaccine.htmlGritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine2021-01-20T13:00:00Z2021-02-06T06:08:09Z— Deal provides nonexclusive access?to Genevant’s leading LNP technology for use in Gritstone’s self-amplifying RNA COVID-19 vaccine program; NIH-sponsored Phase 1 clinical trial expected to initiate in 1Q21 — ]]>2161371enGlobeNewswire Inc.Gritstone Oncology, IncWed, 20 Jan 2021 13:00 GMTHealthLicensing Agreementshttp://www.10gbhost.com/news-release/2021/01/19/2160529/0/en/Advaxis-Announces-Receipt-of-Funding-Milestone-Payment-Under-ADXS-HER2-Licensing-Agreement-with-OS-Therapies.htmlAdvaxis Announces Receipt of Funding Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies2021-01-19T13:00:00Z2021-02-06T06:08:09ZNon-dilutive capital strengthens balance sheet to further advance ADXS-HOT neoantigen program]]>2160529enGlobeNewswire Inc.Advaxis, Inc.Tue, 19 Jan 2021 13:00 GMTLicensing Agreements亚洲精品私拍国产在线播放_亚洲综合区图片小说区_亚洲日本欧美日韩高观看